Relationship between extracellular matrix metalloproteinase inducer and clinical type of coronary heart disease
Junfeng ZHANG; Changqian WANG; Jin WANG; Jing ZHOU; Jun ZHOU; Qiang JIAO; Manghua XU.
Journal of Shanghai Jiaotong University(Medical Science)
; (12): 1431-1433, 2009.
ArtÃculo en Zh | WPRIM | ID: wpr-405138
Documentos relacionados
C-reactive protein and uric acid roles in distinguishing ST-segment elevation myocardial infarction from non-ST-elevation acute coronary syndrome.
[Changes in serum IL-22 level in patients with hypertensive renal damage and its clinical significance].
The impact of type 2 diabetes duration on serum asymmetric dimethylarginine and C-reactive protein concentration in Bosnian patients.
Prognostic value of C-reactive protein to albumin ratio for mortality in acute kidney injury.
Association between natriuretic peptides and C-reactive protein with frailty in heart failure: a systematic review and meta-analysis.
Imbalanced serum levels of resolvin E1 (RvE1) and leukotriene B4 (LTB4) may contribute to the pathogenesis of atherosclerosis.
Serum Hs-CRP level and clinical significance of patients with stress ulcer caused by massive blood loss after trauma.
The relationship between levels of tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in the serum of elderly and acute myocardial infarction.
C-reactive protein-to-serum albumin ratio as a marker of prognosis in adult intensive care population.
[Relationship between atherosclerotic plaque characteristics and extracellular matrix metalloproteinase inducer and urokinase-type plasminogen activator in patients with coronary artery disease].